Shares of Oxford BioMedica plc (LON: OXB) are up 27.9% this year and appear to have recently hit a significant resistance level leading to a sideways trading pattern as buyers build up momentum for a push higher.
A recent article in TheTimes highlighted the significant pay disparity between the biotech company’s US-based directors and its UK staff.
The company defended its pay policy, citing that the higher pay for its US executives attracts “talent from Nasdaq-listed biotechnology businesses”.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Oxford BioMedica noted that over 80% of cell and gene therapy clients, research and companies were based in the United States, making it hard to find and attract talented individuals, hence, the higher pay.
The controversial pay policy will see US non-executive directors earn an extra fee of up to £50,000 annually payable via the issuance of company shares that the director must hold for one year before cashing out.
However, the markets have shrugged off the report that came out on Monday, given that the biotech company’s shares have risen since then and are attempting to break above the resistance level highlighted below.
Oxford BioMedica benefits from its supply agreement with AstraZeneca to manufacture COVID-19 vaccines after the company licensed the vaccine developed at the U University of Oxford.
AstraZeneca recently won a case brought by the European Union seeking to compel the British firm to supply the 300 million doses it had promised after the pharma company reserved a significant portion of the vaccines produced for the UK.
Traders looking to open bullish positions may be better served either waiting for a break above the 1360p level or for a pullback to the 1200-1240p level, which offers a better risk to reward setup.
*This is not investment advice. You should do your due diligence before making investment decisions.
Oxford Biomedica share price.
Oxford Biomedica shares are up 27.96% this year but appear to have hit strong resistance.
